JP Morgan Chase’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-27,200
Closed -$683K 5439
2020
Q2
$683K Buy
+27,200
New +$679K ﹤0.01% 3719
2019
Q2
Sell
-73,400
Closed -$2.15M 5741
2019
Q1
$2.15M Buy
+73,400
New +$2.08M ﹤0.01% 3279

Other funds holding ACHC

JP Morgan Chase's ACHC Position: Q1 2026 in Review

JP Morgan Chase reduced its Acadia Healthcare (ACHC) stake by 55% in Q1 2026, selling an estimated $2.06M and leaving 93,240 shares worth $2.13M. The position accounts for ﹤0.01% of the portfolio, ranked #4056.

JP Morgan Chase first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $341M in Q2 2017. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • JP Morgan Chase held 93,240 shares of Acadia Healthcare worth $2.13M as of Q1 2026.
  • JP Morgan Chase sold 113,593 Acadia Healthcare shares in Q1 2026, an estimated $2.06M.
  • Acadia Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4056 holding.
  • JP Morgan Chase first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's Acadia Healthcare position peaked at $341M in Q2 2017.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.